Targeting Mesothelioma Using an Infectivity Enhanced Survivin-Conditionally Replicative Adenoviruses
Authors:
- Koichi TakayamaKTKoichi Takayama
- Gene P. SiegalGSGene P. Siegal
- Paul N. ReynoldsPRPaul N. Reynolds
- David T. CurielDCDavid T. Curiel
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 1 (7) , 701-711
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Asbestos and mesothelioma: Worldwide trendsLung Cancer, 2005
- The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 ExpressionMolecular and Cellular Biology, 2005
- Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapyGene Therapy, 2004
- Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoterGene Therapy, 2004
- Transcriptional targeting of tumors with a novel tumor-specific survivin promoterCancer Gene Therapy, 2004
- Transcriptional Targeting for Ovarian Cancer Gene TherapyGynecologic Oncology, 2001
- Cancer escape from immune surveillance: How can it be overcome by gene transfer?European Journal of Cancer, 1994
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- Malignant pleural mesothelioma: A survival studyJournal of Surgical Oncology, 1990
- Malignant pleural mesothelioma treatment the current state of the artCancer Treatment Reviews, 1988